Safety and Pharmacology of Stanate

NCT00115544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperbilirubinemia

Interventions

DRUG: Stanate

Sponsor

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

Collaborators

[object Object]